These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 30575958)
1. Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults. Zullo AR; Zhang T; Lee Y; McConeghy KW; Daiello LA; Kiel DP; Mor V; Berry SD J Am Geriatr Soc; 2019 Apr; 67(4):768-776. PubMed ID: 30575958 [TBL] [Abstract][Full Text] [Related]
2. Predictors of Hip Fracture Despite Treatment with Bisphosphonates among Frail Older Adults. Zullo AR; Sorial MN; Lee Y; Lary CW; Kiel DP; Berry SD J Am Geriatr Soc; 2020 Feb; 68(2):256-260. PubMed ID: 31580488 [TBL] [Abstract][Full Text] [Related]
3. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors. Cadarette SM; Solomon DH; Katz JN; Patrick AR; Brookhart MA Osteoporos Int; 2011 Mar; 22(3):943-54. PubMed ID: 20532481 [TBL] [Abstract][Full Text] [Related]
4. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis. Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417 [TBL] [Abstract][Full Text] [Related]
5. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034 [TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study. Zullo AR; Lee Y; Lary C; Daiello LA; Kiel DP; Berry SD Osteoporos Int; 2021 Mar; 32(3):565-573. PubMed ID: 33411003 [TBL] [Abstract][Full Text] [Related]
7. Association Between Bisphosphonates and Hospitalized Clostridioides difficile Infection Among Frail Older Adults. McConeghy KW; Zullo AR; Lary CW; Zhang T; Lee Y; Daiello L; Kiel DP; Berry S J Am Med Dir Assoc; 2020 May; 21(5):688-691. PubMed ID: 31932139 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate use after clinical fracture and risk of new fracture. Bergman J; Nordström A; Nordström P Osteoporos Int; 2018 Apr; 29(4):937-945. PubMed ID: 29397408 [TBL] [Abstract][Full Text] [Related]
9. Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data. Shalev V; Sharman Moser S; Goldshtein I; Yu J; Weil C; Ish-Shalom S; Rouach V; Chodick G Ann Pharmacother; 2017 Sep; 51(9):757-767. PubMed ID: 28535690 [TBL] [Abstract][Full Text] [Related]
10. Hip fractures in users of first- vs. second-generation bisphosphonates. Mamdani M; Kopp A; Hawker G Osteoporos Int; 2007 Dec; 18(12):1595-600. PubMed ID: 17767369 [TBL] [Abstract][Full Text] [Related]
11. Osteoporosis Medications Prevent Subsequent Fracture in Frail Older Adults. Chattaris T; Oh G; Gouskova NA; Kim DH; Kiel DP; Berry SD J Bone Miner Res; 2022 Nov; 37(11):2103-2111. PubMed ID: 36168189 [TBL] [Abstract][Full Text] [Related]
13. Facility and State Variation in Hip Fracture in U.S. Nursing Home Residents. Zullo AR; Zhang T; Banerjee G; Lee Y; McConeghy KW; Kiel DP; Daiello LA; Mor V; Berry SD J Am Geriatr Soc; 2018 Mar; 66(3):539-545. PubMed ID: 29336024 [TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate Use After Hip Fracture in Older Adults: A Nationwide Retrospective Cohort Study. Nordström P; Toots A; Gustafson Y; Thorngren KG; Hommel A; Nordström A J Am Med Dir Assoc; 2017 Jun; 18(6):515-521. PubMed ID: 28238673 [TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of osteoporosis drugs in preventing secondary nonvertebral fractures in Taiwanese women. Lin TC; Yang CY; Yang YH; Lin SJ J Clin Endocrinol Metab; 2013 Dec; 98(12):4717-26. PubMed ID: 24081731 [TBL] [Abstract][Full Text] [Related]
16. Alendronate Use and the Risk of Nonvertebral Fracture During Glucocorticoid Therapy: A Retrospective Cohort Study. Bergman J; Nordström A; Nordström P J Clin Endocrinol Metab; 2018 Jan; 103(1):306-313. PubMed ID: 29126139 [TBL] [Abstract][Full Text] [Related]
17. Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. Cameron ID; Chen JS; March LM; Simpson JM; Cumming RG; Seibel MJ; Sambrook PN J Bone Miner Res; 2010 Apr; 25(4):866-72. PubMed ID: 19839771 [TBL] [Abstract][Full Text] [Related]
18. Fractures and mortality in relation to different osteoporosis treatments. Yun H; Delzell E; Saag KG; Kilgore ML; Morrisey MA; Muntner P; Matthews R; Guo L; Wright N; Smith W; Colón-Emeric C; O'Connor CM; Lyles KW; Curtis JR Clin Exp Rheumatol; 2015; 33(3):302-9. PubMed ID: 25068266 [TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses. Zhou J; Ma X; Wang T; Zhai S Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112 [TBL] [Abstract][Full Text] [Related]
20. RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction. Curtis JR; Westfall AO; Cheng H; Saag KG; Delzell E Osteoporos Int; 2009 Jun; 20(6):973-8. PubMed ID: 18946630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]